Quick Takeaways
- DRIEHAUS CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Apogee Therapeutics, Inc. Common Stock (APGE).
- Disclosed ownership: 4.7%.
- Date of event: 30 Sep 2025.
DRIEHAUS CAPITAL MANAGEMENT LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Apogee Therapeutics, Inc. Common Stock (APGE)
- Filing Manager
- DRIEHAUS CAPITAL MANAGEMENT LLC
- Reporting Manager
- DRIEHAUS CAPITAL MANAGEMENT LLC
- Symbol
- APGE
- Shares outstanding
- 46,121,838 shares
- Disclosed Ownership
- 2,158,502 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 07:27:32 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"DRIEHAUS CAPITAL MANAGEMENT LLC disclosed 4.7% ownership in Apogee Therapeutics, Inc. Common Stock (APGE) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 07:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4.7% | 2,158,502 | 0 | 2,158,502 | Janet McWilliams | Janet McWilliams/General Counsel |